Tracking immune cell migration in tumour and normal tissues after combined radiation-drug therapy in Kaede mice

MRC · United Kingdom government procurement

GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

September 30, 2027
Response Due
Active
Status

Opportunity Overview

Kaede mice are transgenic for a photoactivatable fluorescent protein derived from a stony coral, Trachyphyllia geoffroyi. Following in vivo ultraviolet illumination, cells in the light field irreversibly photoconvert from green to red fluorescence. The candidate will use Kaede mice to track migration and activation/suppression of immune cells (by flow cytometry, fluorescence microscopy, transcriptional profiling) in irradiated and unirradiated tissues. The effects of additional immunomodulatory therapies, including chemotherapy, DNA damage response (DDR) and immune checkpoint inhibitors, will also be assessed. The candidate will analyse the effects of dose-fractionation regimens, lymph node irradiation or shielding and spatial dose-modulation on immune cell trafficking.

This is one of 43 active United Kingdom Pharmaceuticals opportunities most of your competitors will never see.

Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencyMRC
CountryUnited Kingdom
CategoryPharmaceuticals
PublishedOctober 01, 2023
Procurement stageActive solicitation
Response dueSeptember 30, 2027
StatusOpen — accepting responses
Official sourceView original notice
Last verifiedAugust 10, 2026

Source: UK Research and Innovation (UKRI) — Open Government Licence v3.0.

Related Opportunities in United Kingdom

Pharmaceutical Wholesale Services
Community Drug and Alcohol Services
Provision of Drug, Alcohol & DNA Testing Services Framework
Personalised Adaptive Medicine
Repurposing Epigenetic Therapy for Hypertrophic Cardiomyopathy to facilitate the innovation and growth of a N.Ireland Cardiac Drug Development Company
Smallpox Vaccine (2026)
The Provision of Individual Placement and Support (IPS) For Residents Who Access Drug and Alcohol Services in the City of Sunderland Council Area
Preliminary Market Engagement for Pharmaceutical Margin Survey

See every United Kingdom Pharmaceuticals opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free United Kingdom Pharmaceuticals intelligence report in your inbox

A personalized report on United Kingdom Pharmaceuticals opportunities, emailed in 5-10 minutes. One per month, no account needed.